Clinical trials - what areas should Sweden be investing in and in order to attract international investments
Reference number | |
Coordinator | Läkemedelsindustriföreningens Service Aktiebolag |
Funding from Vinnova | SEK 300 000 |
Project duration | April 2019 - January 2020 |
Status | Completed |
Venture | 2017-01599-en |
Important results from the project
** Denna text är maskinöversatt ** The project has fulfilled its aim and goal - to gather and present new knowledge in order to, and in dialogue with relevant parties, propose concrete initiatives with the aim of increasing the number of company-initiated clinical drug trials but also identifying the type of clinical trials in which Sweden has an international competitiveness and therefore should take a position and invest in the future.
Expected long term effects
** Denna text är maskinöversatt ** The survey of Danish investments shows the importance that the state has a clear vision and concrete goals in combination with collaboration, leadership, continuity and long-term vision and how it contributes to the investments having an expected effect. Similarly, the survey in Sweden and what trials we should invest in here show that the forum for collaboration is in demand and that both authorities and companies jointly drive the development forward.
Approach and implementation
** Denna text är maskinöversatt ** The project has been fully implemented in line with the original plan and it has worked out well. There has been a great willingness among respondents to generously assist with knowledge and experience. During the data collection is was decided to add additional interviews to the original number being conducted as we saw that there was more important information out there and that the survey would benefit from in its results, analysis and recommendations.